JUNS (Jupiter Neurosciences) יתרות המזומנים של החברה

Jupiter Neurosciences Inc (JUNS) is implementing "green chemistry" principles for the eco-friendly disposal of reagents. The cash balance confirms the resource dynamics, where this metric equals 0.00. While management possesses deep expertise in neurotherapy, a critical liquidity shortage and the risks of clinical trial failure are exerting significant pressure on the development of the platform for treating neurodegenerative pathologies.
פילוחים אנליטיים ודוחות נתונים של חברת Jupiter Neurosciences (JUNS)

Fundamental asset selection requires liquidity analysis to assess business resilience to market shocks and the cost of borrowed capital. This metric captures the volume of free cash flow, which is critical for Jupiter Neurosciences Inc (JUNS) in overcoming regulatory skepticism toward plant-based drugs; therefore, the cash flow chart on GURU.Markets reflects the company's actual margin of safety in its struggle against pharma behemoths.